Glia

SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation.  70:155-172. 2022

Astrocytes are necessary for blood–brain barrier maintenance in the adult mouse brain.  69:436-472. 2021

Kir5.1-dependent CO2/H⁺-sensitive currents contribute to astrocyte heterogeneity across brain regions.  69:310-325. 2021

Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.  68:1165-1181. 2020

Liver kinase B1 depletion from astrocytes worsens disease in a mouse model of multiple sclerosis.  68:600-616. 2020

Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.  67:2424-2439. 2019

MicroRNA-31 is required for astrocyte specification.  66:987-998. 2018

HuR promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases.  65:945-963. 2017

Two modes of enteric gliotransmission differentially affect gut physiology.  65:699-711. 2017

Plasmalemmal and mitochondrial Na⁺-Ca²⁺ exchange in neuroglia.  64:1646-1654. 2016

Spatio-temporal characteristics of metabotropic glutamate receptor 5 traffic at or near the plasma membrane in astrocytes.  64:1050-1065. 2016

Loose excitation-secretion coupling in astrocytes.  64:655-667. 2016

Expression of familial Alzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environment.  64:317-329. 2016

Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.  63:2285-2297. 2015

GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy.  63:23-36. 2015

Transgenic analysis of GFAP promoter elements.  61:1488-1499. 2013

Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice..  61:679-693. 2013

Hyposmolality differentially and spatiotemporally modulates levels of glutamine synthetase and serine racemase in rat supraoptic nucleus.  61:529-538. 2013

KSRP: A checkpoint for inflammatory cytokine production in astrocytes.  60:1773-1784. 2012

Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.  60:1406-1416. 2012

Regulation of CCL20 expression in astrocytes by IL-6 and IL-17.  60:771-781. 2012

Regulation of microglia effector functions by tumor necrosis factor signaling.  60:189-202. 2012

CONTRIBUTION OF MYELOID SUPPRESSOR OF CYTOKINE SIGNALING 3 TO THE DEVELOPMENT OF NEUROINFLAMMATION.  59:S25-S25. 2011

Alteration Of glial-neuronal metabolic interactions in a mouse model of Alexander disease.  58:1228-1234. 2010

IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia.  58:1082-1093. 2010

Conditional deletion of β1-integrin in astroglia causes partial reactive gliosis.  57:1630-1647. 2009

Dual regulation of Ca21-dependent glutamate release from astrocytes: Vesicular glutamate transporters and cytosolic glutamate levels.  57:1296-1305. 2009

Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.  56:1250-1262. 2008

Ca²⁺ entry through TRPC1 channels contributes to intracellular Ca²⁺ dynamics and consequent glutamate release from rat astrocytes.  56:821-835. 2008

GFAP promoter elements required for region-specific and astrocyte-specific expression.  56:481-493. 2008

Vesicular transmitter release from astrocytes.  54:700-715. 2006

HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1β.  54:619-629. 2006

Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.  53:677-687. 2006

Functional expression of Kir4.1 channels in spinal cord astrocytes.  53:516-528. 2006

Divergent effects of oncostatin M on astroglioma cells: Influence on cell proliferation, invasion, and expression of matrix metalloproteinases.  53:191-200. 2006

Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells.  47:9-20. 2004

GFAP: Functional implications gleaned from studies of genetically engineered mice.  43:87-90. 2003

Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: Synergy with interleukin-1β, tumor necrosis factor-α, and bacterial lipopolysaccharide.  42:433-446. 2003

Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain.  37:328-336. 2002

Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain..  37:328-336. 2002

Immune function of astrocytes.  36:180-190. 2001

Transcriptional regulation of the intercellular adhesion molecule-1 gene by proinflammatory cytokines in human astrocytes..  25:21-32. 1999

Cleavage of membrane-associated ICAM-1 from astrocytes: Involvement of a metalloprotease.  22:103-112. 1998

Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes.  22:171-179. 1998

Cytokines and tumors of the central nervous system.  15:264-288. 1995

Interleukin 1‐β‐ and tumor necrosis factor‐α‐mediated regulation of ICAM‐1 gene expression in astrocytes requires protein kinase C activity.  14:267-278. 1995

Microglial tyrosine phosphorylation systems in normal and degenerating brain.  11:284-290. 1994

Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cells.  7:225-236. 1993